The researchers found that with denosumab vs oral bisphosphonates, the risk for emergently treated hypocalcemia increased with worsening CKD stage. (HealthDay News) — For patients with chronic ...

It is also essential for neurotransmission and neuronal excitability ... hypomagnesemia, hypocalcemia, or both hypomagnesemia and hypocalcemia. Cognitive performance was assessed using the ...

Worsening CKD was progressively associated with denosumab-induced hypocalcemia warranting emergency treatment. Denosumab use carries a higher risk for emergency hypocalcemia compared with ...